Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bath & Body Works, Inc.BBWI · Entity 4091 | Chief Financial Officer | March 12, 2026 | March 16, 2026 |
| CVS HEALTH CorpCVS · Entity 2884 | EVP & CFO | May 04, 2021 | May 06, 2021 |
| Cencora, Inc.COR · Entity 2994 | Chief Financial Officer | June 29, 2026 | June 30, 2026 |
| UNITED PARCEL SERVICE INCUPS · Entity 2301 | Director | May 07, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bath & Body Works, Inc.
Report date March 12, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.50 par valueSEC Table I · non-derivative | Direct | 223,459 |
Ending reported balance
After 2026-03-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-12 · Grant · Acquired 115,815 · Balance 234,241 F1: Annual grant of restricted stock units vesting 30% on the first anniversary of March 12, 2026 (the "Grant Date"), 30% on the second anniversary of the Grant Date and 40% on the third anniversary of the Grant Date. Row 2 · 2026-03-13 · Tax withholding · Disposed 10,782 · Balance 223,459 F2: Represents shares withheld in connection with the vesting of restricted stock units to cover tax withholding obligations. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant of restricted stock units vesting 30% on the first anniversary of March 12, 2026 (the "Grant Date"), 30% on the second anniversary of the Grant Date and 40% on the third anniversary of the Grant Date.
F2: Represents shares withheld in connection with the vesting of restricted stock units to cover tax withholding obligations.
CVS HEALTH Corp
Report date May 04, 2021 · Filed May 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,331.0445 |
Reported balance
After 2021-05-04 transaction · row 1
1 source rowRow 1 · 2021-05-04 · Sale · Disposed 4,905 · Balance 115,331.0445 F1: All sales were effected pursuant to a Rule 10b5-1 plan. |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 2,242 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,242 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $102.26 · Expires 2022-04-01 | Direct | 27,392 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 27,392 F2: Option became exercisable in four equal annual installments, commencing 4/1/2016. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 21,509 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 21,509 F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 35,062 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 35,062 F4: Option became exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $62.21 · Expires 2025-04-01 | Direct | 35,030 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 35,030 F5: Option became exercisable in four equal annual installments, commencing 4/1/2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 202,007 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 202,007 F6: Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 168,956 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 168,956 F7: The number of shares subject to the option were calculated using a 30-day average price. F8: Options became exercisable in four equal annual installments, commencing 4/1/2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.30 · Expires 2031-04-01 | Direct | 103,663 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 103,663 F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. |
Filing footnotes · ownership attribution and instrument terms
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
F4: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7: The number of shares subject to the option were calculated using a 30-day average price.
F8: Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
Cencora, Inc.
Report date June 29, 2026 · Filed June 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 21,304 |
Reported balance
After 2026-06-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-29 · Grant · Acquired 21,304 · Balance 21,304 F1: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 6/29/2027, 6/29/2028, and 6/29/2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 6/29/2027, 6/29/2028, and 6/29/2029.
UNITED PARCEL SERVICE INC
Report date May 07, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,948.8064 |
Reported balance
After 2026-05-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 1,948 · Balance 9,948.8064 F1: One unit is equivalent to one share of UPS Class A common stock. F2: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3: Includes units credited upon the payment of dividends on the underlying Class A common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: One unit is equivalent to one share of UPS Class A common stock.
F2: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director.
F3: Includes units credited upon the payment of dividends on the underlying Class A common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2014 Filed Feb 20, 2014 21:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 460 | $70.10 | $32,246.00 |
DisclosureSEC source: 0001127602-14-007477 · form4.xml · nonDerivative · entry 3 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,736.9542 F3 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 3,075 | $70.32 | $216,234.00 |
DisclosureSEC source: 0001127602-14-007477 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,503 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing February 18, 2015. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,844 | $70.32 | $199,990.08 |
DisclosureSEC source: 0001127602-14-007477 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,817.9542 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 15, 2014 Filed Feb 18, 2014 21:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 293 | $69.90 | $20,480.70 |
DisclosureSEC source: 0001127602-14-006769 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,812.8102 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 07, 2014 Filed Feb 10, 2014 21:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 267 | $66.44 | $17,739.48 |
DisclosureSEC source: 0001127602-14-005387 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,204.8102 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| November 22, 2013 Filed Nov 25, 2013 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 6,654 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-13-032780 · form4.xml · derivative · entry 5 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,965 Underlying: Common Stock · 6,654 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| November 22, 2013 Filed Nov 25, 2013 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 6,654 | $66.50 | $442,491.00 |
DisclosureSEC source: 0001127602-13-032780 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,677.7198 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 22, 2013 Filed Nov 25, 2013 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 6,654 | $45.07 | $299,895.78 |
DisclosureSEC source: 0001127602-13-032780 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,331.7198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2013 Filed Nov 7, 2013 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 6,029 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-13-030883 · form4.xml · derivative · entry 5 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,058 Underlying: Common Stock · 6,029 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| November 05, 2013 Filed Nov 7, 2013 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 6,029 | $63.50 | $382,841.50 |
DisclosureSEC source: 0001127602-13-030883 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,677.7198 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 05, 2013 Filed Nov 7, 2013 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 6,029 | $34.96 | $210,773.84 |
DisclosureSEC source: 0001127602-13-030883 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,706.7198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2013 Filed Oct 21, 2013 19:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 11,053 | $0.00 Strike: $30.16 | $0.00 |
DisclosureSEC source: 0001127602-13-029551 · form4.xml · derivative · entry 5 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,214 Underlying: Common Stock · 11,053 shares Expires 2020-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 7/19/2013. Read SEC document |
| October 18, 2013 Filed Oct 21, 2013 19:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 11,053 | $60.50 | $668,706.50 |
DisclosureSEC source: 0001127602-13-029551 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,677.7198 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 18, 2013 Filed Oct 21, 2013 19:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 11,053 | $30.16 | $333,358.48 |
DisclosureSEC source: 0001127602-13-029551 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,730.7198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2013 Filed Oct 15, 2013 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 11,053 | $0.00 Strike: $30.16 | $0.00 |
DisclosureSEC source: 0001127602-13-029304 · form4.xml · derivative · entry 5 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,267 Underlying: Common Stock · 11,053 shares Expires 2020-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 7/19/2013. Read SEC document |
| October 11, 2013 Filed Oct 15, 2013 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 11,053 | $59.50 | $657,653.50 |
DisclosureSEC source: 0001127602-13-029304 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,677.7198 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 11, 2013 Filed Oct 15, 2013 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 11,053 | $30.16 | $333,358.48 |
DisclosureSEC source: 0001127602-13-029304 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,730.7198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.